{
  "patientFirstName": "Carol",
  "patientLastName": "Nakamoto",
  "patientDateOfBirth": "1977-01-01",
  "patientEmail": "email@email.com",
  "reportDate":"2025-11-04",
  "diagnosisDate": "2025-08-02",
  "diagnosisSummary": "Mixed metastatic invasive lobular and ductal carcinoma",
  "tumors": [
  {
  	"name": "Lobular Carcinoma In Situ (LCIS)",
    "location": "Right breast: 2 small tumors (0.4cm and 0.6cm)<br>Axillary lymph node (0.5cm)",
  	"stage": "Stage IV",
  	"grade": "Grade 1",
  	"hormoneReceptorStatus": "Hormone Receptor Positive (HR+)",
  	"her2Status": "HER2 positive (HER2+)"
  },
   {
  	"name": "Tumor 1",
    "location": "Right breast: 2 small tumors (0.4cm and 0.6cm)",
  	"stage": "Stage III",
  	"grade": "Grade 3",
  	"hormoneReceptorStatus": "Hormone Receptor Positive (HR+)",
  	"her2Status": "HER2 positive (HER2+)"
  },
     {
  	"name": "Tumor 2",
    "location": "Right breast: 2 small tumors (0.4cm and 0.6cm)",
  	"stage": "Stage IV",
  	"grade": "Grade 3",
  	"hormoneReceptorStatus": "Hormone Receptor Positive (HR+)",
  	"her2Status": "HER2 positive (HER2+)"
  },
    {
  	"name": "Tumor 3",
    "location": "Axillary lymph node (0.5cm)",
  	"stage": "Stage III",
  	"grade": "Grade 3",
  	"hormoneReceptorStatus": "Estrogen Receptor Positive (ER+)",
  	"her2Status": "HER2 low"
  }
  ],
  "whatThisMeans": {
      "goodNews": "Because your cancer is hormone receptor positive, endocrine therapy can be very effective at slowing or stopping cancer growth.",
      "newOptions": "Newer targeted treatments for HER2-low breast cancer may become part of your plan.",
      "treatmentFocus": "Since the cancer is metastatic, treatment focuses on controlling the disease and helping you feel as well as possible."
  },
  "testsCompleted": [
  {
  	"name": "Breast imaging (diagnostic mammogram and ultrasound)",
    "date": "October 12, 2025",
    "explanation": "Description goes here"

  },
  {
  	"name": "MRI-Guided Biopsy",
    "date": "October 15, 2025",
    "explanation": "Tissue sample taken using magnetic resonance imaging to locate and target suspicious breast area."

  },
    {
  	"name": "Tumor Markers (CA 15-3, CA 27.29, CEA)",
    "date": "October 22, 2025",
    "explanation": "Measures proteins that cancer cells may release into blood, used to monitor disease progression or recurrence."

  },
  {
  	"name": "Complete Blood Count (CBC)",
    "date": "October 22, 2025",
    "explanation": "Checks red blood cells, white blood cells, and platelets to ensure body is healthy enough for treatment"
  }
],
  "testsNeeded": [
  {
  	"name": "PET/CT scan (full body scan)",
    "date": "October 12, 2025",
    "explanation": "To see the complete picture of where cancer has spread"

  },
    {
  	"name": "Echocardiogram (heart ultrasound)",
    "date": "October 15, 2025",
    "explanation": "To make sure your heart is healthy before starting certain treatments"

  },
    {
  	"name": "Germline genetic testing",
    "date": "October 22, 2025",
    "explanation": "Blood test to check for inherited cancer gene changes (like BRCA1/BRCA2)"

  },
    {
  	"name": "Additional blood tests",
    "date": "October 22, 2025",
    "explanation": "Thyroid, Vitamin D, Vitamin B12"

  }
],
  "treatmentTeam": {
    "oncologist": "Dr. Melissa Chang",
    "surgeon": "Dr. Rachel Nguyen",
    "radiologist": "Dr. James Patel"
  },
  "resources": [
    {
      "title": "Understanding Your Pathology Report",
      "url": "https://defianthealth.com/pathology-guide"
    },
    {
      "title": "What to Ask Your Oncologist",
      "url": "https://defianthealth.com/questions"
    },
    {
      "title": "Support Services",
      "url": "https://defianthealth.com/support"
    }
  ],
  "contactInfo": {
    "phone": "617-555-2487",
    "email": "navigator@defianthealth.com"
  }
}